Shatavari vs Ashwagandha: Which Is Better for Women?

Two Ayurvedic roots dominate women's-health conversations: shatavari vs ashwagandha — which one should women take? They're often sold side by side but are fundamentally different medicines. Shatavari (Asparagus racemosus) is a traditional female reproductive tonic with phytoestrogenic activity and new menopause trial data; ashwagandha (Withania somnifera) is an adaptogen studied for stress, cortisol, sleep, and thyroid function. This guide compares mechanisms, trial evidence, doses, safety, and which one matches your goal.

About Shatavari

Shatavari (Asparagus racemosus) is one of Ayurveda's principal herbs for female reproductive health. Its key constituents are steroidal saponins called shatavarins, and the herb is described as having phytoestrogenic activity — plant compounds with affinity for estrogen receptors, far more weakly than human estrogen (Alok et al., 2013). The honest framing: this activity has been demonstrated mainly in preclinical models (rodent studies showing estrogen-like effects on reproductive tissues); direct evidence of clinically meaningful estrogenic action in women is still limited.

What the trials show: Shatavari's modern evidence base is young but growing fast. Two 2025 randomized trials tested shatavari root extract in peri-/menopausal women. Ademola et al. (Frontiers in Reproductive Health; n=135 women aged 45–65; 8 weeks; 300 mg/day standardized to >10% shatavarins) found shatavari alone significantly reduced Menopause Rating Scale (MRS) and perceived-stress scores versus placebo (PMID 41394012). Mahajan et al. (International Journal of Women's Health; n=80 perimenopausal women; 300 mg/day for 8 weeks) reported total MRS scores fell 42.6% versus 5.5% with placebo, hot-flash scores fell 26% versus 7%, and no adverse events occurred. Earlier small studies explored shatavari for lactation support — a double-blind trial by Gupta and Shaw (2011; n=60 lactating mothers) found 60 mg/kg/day for 30 days more than tripled prolactin versus control — though a review of galactagogues (Bazzano et al., 2016) notes results across the few shatavari trials are inconsistent, so the evidence stays modest. The honest caveat: shatavari's human trial record is thin compared to ashwagandha's — promising, but early.

About Ashwagandha

Ashwagandha (Withania somnifera) is an adaptogen — studied for helping the body manage stress. Its actives are withanolides, and it is among the most clinically studied Ayurvedic herbs, though most trials enrolled mixed-gender populations rather than women specifically.

What the trials show: Stress and cortisol — multiple RCTs report reduced perceived stress and lower serum cortisol. The most cited, Chandrasekhar et al. (Indian Journal of Psychological Medicine, 2012; PMID 23439798), randomized 64 chronically stressed adults to 300 mg twice daily for 60 days and found significant reductions in stress-assessment scores (p<0.0001) and serum cortisol (p=0.0006) versus placebo, with mild adverse effects comparable to placebo. Sleep — Langade et al. (Cureus, 2019) randomized 60 insomnia patients to 300 mg twice daily for 10 weeks and reported significantly shorter sleep-onset latency (p=0.019) and improved sleep efficiency and sleep quality (p=0.002) versus placebo; a second trial (Langade et al., Journal of Ethnopharmacology, 2020; n=80) found 600 mg/day for 8 weeks improved sleep-onset latency, wake-after-sleep-onset, and PSQI scores. Thyroid — a pilot RCT (Sharma et al., Journal of Alternative and Complementary Medicine, 2018) in 50 adults with subclinical hypothyroidism found 600 mg/day for 8 weeks significantly improved TSH (p<0.001; down 17.4% at 8 weeks), T3 (p=0.0031; up 41.5%), and T4 (p=0.0096; up 19.6%) versus placebo — the basis for both interest and caution. Women's health specifically — a pilot trial in 50 women (Dongre et al., BioMed Research International, 2015) found 300 mg twice daily for 8 weeks improved FSFI domains of arousal, lubrication, orgasm, and satisfaction versus placebo (desire was not significantly improved); a 2025 menopause trial also tested shatavari + ashwagandha in combination. Still, the women's-specific base is smaller than the general adaptogen literature.

The honest caveat: ashwagandha is not a women's-hormone herb the way shatavari is. Its benefits for women come mostly through stress, sleep, and cortisol — which matter enormously for hormonal health, but indirectly.

Head-to-Head Comparison

Dosage Guide

Trial regimens and traditional use — not prescriptions. Shatavari dosing is less standardized than ashwagandha's, itself a sign of its younger evidence base.

Form notes: For shatavari, root extracts standardized for shatavarins (the 2025 trials used ≥10% shatavarins at 300 mg/day) are the closest to trial-tested dosing. For ashwagandha, the best-studied forms are root-only extracts standardized for withanolides (e.g., the KSM-66 extract was used in the Dongre 2015 and Langade 2020 trials); most trials used root-only extracts, so their safety findings apply most directly to root products.

Safety & Interactions

Shatavari — gentle but hormonally active. Good tolerability in human data; mild GI upset is the main complaint. The key caution is phytoestrogenic activity (demonstrated mainly in preclinical models): as a precaution, women with estrogen-sensitive conditions (hormone-receptor-positive breast cancer, endometriosis, uterine fibroids) should not self-supplement — discuss with their oncologist or gynecologist. A mild diuretic effect has been reported in rat studies at high doses only (Kumar et al., West Indian Medical Journal) — human relevance is unclear. Drug-interaction data is sparse — a reason for clinician guidance, not reassurance.

Ashwagandha — well-studied but with real cautions. Common effects are mild: GI upset and drowsiness (don't combine with alcohol or drive until you know your response). The serious cautions: pregnancy — avoid (NCCIH: avoid during pregnancy and while breastfeeding); thyroid medication — a pilot trial showed it can raise T3/T4 and lower TSH (Sharma 2018), which could require dose adjustments of thyroid drugs; NCCIH notes possible interactions with thyroid hormone medications — monitor thyroid labs with your doctor; sedatives/immunosuppressants — NCCIH notes possible interactions with sedatives, immunosuppressants, and diabetes and blood-pressure drugs; liver injury — rare case reports exist (Björnsson et al., Liver International, 2020: 5 cases of cholestatic/mixed injury after 2–12 weeks of use, all with jaundice, self-limited within 1–5 months of stopping) — stop use for jaundice, dark urine, or upper-right abdominal pain.

Cautious with either: pregnancy/breastfeeding (ashwagandha is an avoid; shatavari needs clinician guidance), thyroid medication (ashwagandha), hormone-sensitive conditions (shatavari), sedatives or multiple prescriptions.

Which Should You Choose?

• Menopause symptoms → Shatavari: the only one with direct menopause RCT data (Ademola 2025; Mahajan 2025) plus a phytoestrogen rationale.
• Stress, anxiety, or high cortisol → Ashwagandha: the deeper, better-replicated evidence base.
• Sleep problems → Ashwagandha: trial-backed for sleep quality; shatavari has little sleep data.
• Cycle irregularity or hormonal balance → Shatavari: traditional use and mechanism fit; ashwagandha's benefit is indirect.
• Thyroid concerns or thyroid medication → Neither without your doctor — ashwagandha actively affects thyroid hormones.
• Trying to conceive or pregnant → Neither without your OB-GYN.

Short version: shatavari is the hormonal pick, ashwagandha is the stress-and-sleep pick.

Can You Take Them Together?

Both herbs appear together in Ayurvedic polyherbal preparations (e.g., Shatavari Guggulu-type formulas) and many modern products — one traditionally aimed at reproductive pathways, the other at stress pathways. Notably, one modern trial has tested the combination: the 8-week, 135-woman RCT by Ademola et al. (2025) included a shatavari (300 mg) + ashwagandha (250 mg) arm for menopausal symptoms and found it outperformed both shatavari alone and placebo, with only mild GI events (loose stools, dizziness) — though larger, longer trials are still needed to confirm safety and added benefit. Each herb's cautions still apply (thyroid meds, pregnancy, hormone-sensitive conditions). If a clinician recommends both, start them separately to attribute effects correctly.

📢 Disclaimer: This information is for educational purposes only and is not medical advice. Always consult a qualified healthcare professional before starting any new supplement. Sources are linked for verification.

Explore the Full Remedy Database

Browse 500+ organic alternatives for health, wellness, and natural living.